Neurophet AQUA is an artificial intelligence-based degenerative brain disease diagnosis assistant software that helps clinicians to diagnose brain MRI data through quantitative analysis.
Product specifications Information source: Vendor
Last updated: May 31, 2021
General
Product name Neurophet AQUA
Company Neurophet
Subspeciality Neuro
Modality MR
Disease targeted Mild cognitive impairment, Alzheimer's disease, dementia
Key-features brain region segmentation, volume quantification, normative comparison, report generation, white matter hyperintensity quantification, multi-time-point analysis.
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population All brain MR
Input 3D T1 weighted image
Input format DICOM
Output Color-coded segmentation overlays, configurable reports with reference statistics, pre-populated radiological reporting template
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS)
Deployment Locally on dedicated hardware
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes
Certification
CE
Certified, Class IIa , MDD
FDA
No or not yet
Market presence
On market since 03-2020
Distribution channels
Countries present (clinical, non-research use) 1
Paying clinical customers (institutes) 15
Research/test users (institutes) 50
Pricing
Pricing model Subscription, One-off payment
Based on Pay-per-scan
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers